Drug Topics

FEBRUARY 5, 2025

The prevalence of high blood pressure is highest in Mississippi at 40.2% compared with the lowest in Colorado at 24.6%.

493

493

STAT

FEBRUARY 3, 2025

United Therapeutics said Monday that the Food and Drug Administration has cleared it to begin the first clinical trial testing whether organs from gene-edited pigs could provide a viable option for patients in dire need of an organ transplant. Over the last three years, United and a rival company, eGenesis, have transplanted genetically modified pig hearts or kidneys into several patients, but those procedures were done through compassionate use waivers from the FDA that allow doctors to treat i

FDA 125

FDA 125

European Pharmaceutical Review

FEBRUARY 3, 2025

The US Food and Drug Administration (FDA) has sent a warning letter to KVK-Techs drug manufacturing facility following an inspection in April 2019. The document identified significant violations of current good manufacturing practice (cGMP) regulations for finished pharmaceuticals. The FDA issued the warning letter to KVK-Tech in February 2020, advising that due to these cGMP breaches, the companys products are adulterated according to the Federal Food, Drug, and Cosmetic Act (FD&C Act).

FDA 88

FDA Documentation 88

PharmaVoice

FEBRUARY 3, 2025

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are coming through the pipes if it does.

Vaccines 217

Vaccines 217

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

FEBRUARY 1, 2025

In their exploration of 2 separate respiratory virus seasons, researchers examined the severity of illness for SARS-CoV-2, influenza, and respiratory syncytial virus.

629

629

STAT

FEBRUARY 3, 2025

People with celiac disease face a food paradox. Gluten-free bagels, brownie mixes, and frozen burritos beckon from grocery store shelves. Yet despite this abundance, they can’t trust that these foods are actually safe to eat. The story of how the food industry went gaga for gluten-free products, putting the health of people with celiac at risk in the process, takes center stage in Emily Abel’s new book, “Gluten Free for Life: Celiac Disease, Medical Recognition, and the Food

Grocery Stores 120

Grocery Stores Labelling FDA 120

PharmaVoice

FEBRUARY 7, 2025

While the 10% tariff on Chinese goods won’t have too much impact on branded drugs, generics are struggling to pivot.

173

173

Drug Topics

FEBRUARY 4, 2025

In a systematic review, researchers explored how biofeedback impacted rehabilitation in patients experiencing chronic pain disorders.

464

464

STAT

FEBRUARY 3, 2025

Is China setting the global standard for AI-driven drug development? DeepSeek, a relatively unknown AI firm based in Hangzhou, China, shocked the industry last week with claims that its technology could rival the abilities of technologies developed by leading U.S. AI companies — and do so far more economically. The claims ignited debates not just about the implications for AI companies like OpenAI but for the U.S. drug industry, which is increasingly turning to AI in hopes of develop

121

121

Pharmacy Times

FEBRUARY 4, 2025

Investigators noted that the differences between the 3 respiratory infections were not as pronounced during the 2023-2024 season.

157

157

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Checkup by Singlecare

FEBRUARY 4, 2025

Farxiga and Jardiance are two brand-name oral medications approved by the U.S. Food and Drug Administration (FDA) to manage Type 2 diabetes mellitus. Both are sodium-glucose cotransporter 2 (SGLT2) inhibitors. Farxiga, manufactured by AstraZeneca, contains the active drug dapagliflozin, and Jardiance, manufactured by Boehringer Ingelheim Pharmaceuticals, contains the active drug empagliflozin.

Hospitals 52

Hospitals Insurance Insurance Coverage Adverse Reactions 52

Drug Topics

FEBRUARY 6, 2025

Experts believe a bird flu outbreak is responsible for hundreds of dead birds washing ashore on the beaches of Chicago.

453

453

STAT

FEBRUARY 3, 2025

This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday.  Sign up here.  The most sustainable, and personally meaningful, way to fund journalism is through viewers like you. STAT is running a 50% discount right now. If it makes sense for you financially, think about it. This newsletter and my inbox are always here for you, too: bob.herman@statnews.com.

Insurance 123

Insurance 123

Pharmacy Times

FEBRUARY 7, 2025

Donna Ryan discusses the landscape of GLP-1 medications and the lineup of indications that the drug class has received indications for in recent years.

153

153

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

FEBRUARY 5, 2025

Government unions and cybersecurity experts are disturbed by Elon Musk's newfound access to personal information and the country's payment infrastructure, which coordinates funds for government health programs like Medicare and Medicaid.

140

140

Drug Topics

FEBRUARY 3, 2025

Approximately 29% of patients were also more likely to refill their medication, leading investigators to consider an association between medication adherence.

444

444

STAT

FEBRUARY 3, 2025

Women’s health champions like us cheered in January when the U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation for cervical cancer screening for high-risk genotypes of human papillomavirus (HPV), including the use of self-collection tests. The move follows the Food and Drug Administration’s approval of self-collection tests last summer.

FDA 97

FDA 97

Pharmacy Times

FEBRUARY 3, 2025

Rising seasonal viruses and emerging concerns emphasize the need for public awareness and prevention.

144

144

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

DiversifyRx

FEBRUARY 4, 2025

Your pharmacy team will either be your greatest strength or your weakest link. Pharmacy Team development is a critical pillar for independent pharmacy owners aiming to enhance operational efficiency, boost employee satisfaction, and improve patient care. Investing in your team’s growth fosters a positive work environment and directly contributes to your pharmacy’s success.

Independent Pharmacies 52

Independent Pharmacies Patient Care Communication 52

Drug Topics

FEBRUARY 7, 2025

The American Pharmacists Association announced the launch of its transformative HealthShifts platform in collaboration with the California Pharmacists Association and powered by Locumate.

345

345

STAT

FEBRUARY 3, 2025

To many, Robert F. Kennedy Jr. appears to advocate positions that are contrary to scientific orthodoxy, but there’s one area where he and his critics largely agree: Healthier eating leads to a healthier population. Obesity, for instance, is a major and costly health problem that is only getting worse. Excess body fat and obesity are linked to type 2 diabetes, coronary artery disease, and hypertension, among other ailments.

88

88

Pharmacy Times

FEBRUARY 5, 2025

The initiative will provide information about care models for specialists and clinical teams to improve patient outcomes in heart failure.

142

142

Fierce Healthcare

FEBRUARY 6, 2025

The storm decimated half a dozen states, killing hundreds and forcing local health systems to contend with the fallout. Some hospitals were well prepared. Others were destroyed. Everyone was doing what they could to figure out contingencies on the fly. This, experts warn, will not be the last time.

Hospitals 133

Hospitals 133

Drug Topics

FEBRUARY 4, 2025

Children with type 1 diabetes who watched educational videos and played games had improved glycemic control and quality of life.

335

335

STAT

FEBRUARY 3, 2025

Vaccines do not cause autism. You’ve almost certainly read that before — probably hundreds of times. But many people do not believe it, perhaps because too often it is repeated without a real explanation of how we know that. So here is an attempt to offer that explanation.

Vaccines 145

Vaccines 145

Pharmacy Times

FEBRUARY 7, 2025

The designation builds on previous regulatory action for ADI-001 and allows for expedited development of the treatment for systemic lupus erythematosus.

FDA 138

FDA 138

Fierce Healthcare

FEBRUARY 6, 2025

Managers across the health agencies were tasked with categorizing their probationary workers to determine those who were not mission critical, according to two new media reports citing internal sources.

131

131

Drug Topics

FEBRUARY 5, 2025

ADI-001 is an investigation allogeneic gamma delta chimeric antigen receptor T cell therapy that targets CD20 for the treatment of a variety of autoimmune diseases.

FDA 331

FDA 331

PharmaVoice

FEBRUARY 7, 2025

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and around 1,000 prescriptions weekly by late January.

130

130

Pharmacy Times

FEBRUARY 4, 2025

Investigators found that 60% of individuals with type 2 diabetes are vitamin D deficient.

136

136

The FDA Law Blog

FEBRUARY 2, 2025

By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drug delivery requirements. The rules were implemented to enhance patient safety protections via revised drug handling, packaging, and delivery requirements.

Packaging 59

Packaging Documentation Compounding 59

Drug Topics

FEBRUARY 3, 2025

In a phase 1b/2a clinical trial, investigators evaluated the once weekly subcutaneous drug for safety, tolerability, pharmacokinetics, and proof-of-concept.

331

331

PharmaVoice

FEBRUARY 6, 2025

The market has been no less demanding for pharma giants as 2025 begins, but last year’s strategies are paying off.

130

130